Key result
Systematic review protocol outlines planned evaluation of deprescribing interventions on older adult health and mortality.
Why the study?
Do deprescribing interventions improve health, quality of life, and mortality in people aged 65 years and above?
Systematic Review
Do deprescribing interventions improve health, quality of life, and mortality in people aged 65 years and above?
This protocol outlines a systematic review to evaluate the safety and effectiveness of deprescribing interventions on clinical outcomes in older adults.
Answers are grounded in this paper and cite their sources.
Protocol for deprescribing review in older adults will synthesize safety and effectiveness data; leaves open practice change until results emerge.
Review question/objective The objective of this review is to identify the effectiveness of deprescribing interventions on health-related outcomes. More specifically, the objectives are to identify: The effectiveness of deprescribing interventions on health, quality of life and mortality in older people, defined as those aged 65 years and above. Background Older people commonly use multiple medicines to manage chronic health conditions. In this population, medicines are frequently associated with adverse drug reactions (ADRs), falls risk and may have a negative impact on both cognition and quality of life.1 There is often genuine uncertainty whether the benefit or risk of taking the medication is greater. Medication-related harms are a significant public health risk in the older population. It is estimated that at least 80,000 Australian hospital admissions annually are related to medication use.2 Evidence demonstrates that over 40% of a-related hospital admissions may be preventable.3 The news does not improve post-discharge, where 17.7% of older people with hospital admissions for ADRs are readmitted with a follow-up ADR within three years.4 The prevalence of medication-related harm highlights the potential for medications to cause significant harm as well as benefit in older people. There is reasonable doubt if older people benefit from all of their medications.5 Long-term antihypertensive, diuretic, antipsychotic and hypnotic medications can be ceased in a sizeable minority of older people without symptom return.5 For example, the second Australian national blood pressure study cohort found that 36% of normotensive older people treated with antihypertensive medications remained normotensive post-withdrawal.6 This evidence suggests a significant minority of older people take unnecessary medications. The factors and reasons for this are poorly understood, though may include disease progression, physiological ageing, or lifestyle changes. Deprescribing is hypothesized as an intervention to reduce the risks associated with older people using medicines.7 Deprescribing balances the expected benefits from medication against the known risks, accounting for potential drug interactions, ADRs, co-morbidities and life expectancy.5 Deprescribing includes drug withdrawal, drug discontinuation, tapering, or even substitution of the target medicine.8, 9 Medications are tapered when a rebound syndrome or physiological withdrawal is expected.10, 11 First appearing in the literature in 2003, the term deprescribing is a growing area of research.12 The first review on the topic in 2008 supported evidence that some medications could be safely and successfully withdrawn.5 A 2009 systematic literature review discussed criteria for inappropriate medications and interventions to reduce their use including, but not limited to, regulatory policies, pharmacist-based, geriatric medicine services and multidisciplinary team-based interventions.13 A 2012 review investigated the risks of polypharmacy, the challenges of discontinuing medications, interventions to reduce medication prescribing and the effectiveness of interventions to reduce medication exposure and found that although different interventions can reduce medication exposure, the evidence for clinical efficacy and sustainability is both insufficient and conflicting.14 In 2013, a qualitative systematic review investigated the patient-reported barriers and enablers to deprescribing that discussed patient attitudes and perceptions of medications and found that multiple competing enablers and barriers influence a consumer's decision to deprescribe a medication.15 One of the major drawbacks of these reviews is that they discussed the effect on clinical outcomes of withdrawing only one medication, or only the intervention to withdraw the medication. The proposed systematic review will investigate the effectiveness of deprescribing one or more medications and their effect on clinical outcomes for older people, and more importantly if it is safe.
No takes yet. Share an insight, caveat, or question.
Page et al. (2014) conducted a systematic review in Polypharmacy and medication-related harm. Deprescribing interventions was evaluated on Health, quality of life and mortality. This systematic review protocol outlines a planned investigation into the effectiveness of deprescribing interventions in older adults, and thus reports no quantitative results.
Synapse has enriched 10 related papers. Consider them for comparative context: